The global angiography devices market to grow at a CAGR of 6.06% during the period 2017-2021.
The report, Global Angiography Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
According to the report, medical facilities worldwide are shifting toward minimally invasive procedures that involve the use of radiotherapy and imaging technologies, expanding the treatment options for peripheral vascular diseases (PVDs) such as deep vein thrombosis. The deposition of fatty acids in blood vessels of the legs and arms can cause blood clots that restrict normal blood flow. If left untreated, PVDs can cause heart attacks and stroke, leading to death.
To treat the disease, physicians perform angioplasty or insert stents in the blood vessels through minimally invasive surgeries. Radiologists who use interventional angioplasty to use catheters or stents to the femoral artery also adopt minimally invasive procedures. These methods help minimize trauma and pain, and reduce the risks of infection in blood vessels.
- Abbott Laboratories
- Boston Scientific
- Cardinal Health
Other Prominent Vendors
- Aachen Resonance
- AV Medical
- B. Braun Melsungen
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end user
PART 08: Geographical segmentation
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/5n7qm2/global